Vulvovaginitis in healthy women

Compr Ther. Jun-Jul 1999;25(6-7):335-46. doi: 10.1007/BF02944280.

Abstract

Vulvovaginal symptoms are extremely common and result in millions of visits to practitioners' offices, STD clinics and emergency rooms. Vaginal infections or infectious vaginitis is responsible for only a minority of symptoms and is readily diagnosed. Epidemiology, diagnosis and therapy of vaginitis is reviewed.

Publication types

  • Review

MeSH terms

  • Adult
  • Animals
  • Anti-Infective Agents, Local / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antitrichomonal Agents / therapeutic use
  • Atrophy
  • Candidiasis, Vulvovaginal / diagnosis
  • Candidiasis, Vulvovaginal / drug therapy
  • Clotrimazole / therapeutic use
  • Diagnosis, Differential
  • Dyspareunia / etiology
  • Female
  • Fluconazole / therapeutic use
  • Humans
  • Imidazoles / therapeutic use
  • Itraconazole / therapeutic use
  • Ketoconazole / therapeutic use
  • Male
  • Miconazole / therapeutic use
  • Middle Aged
  • Nystatin / therapeutic use
  • Ornidazole / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Parasitic / diagnosis
  • Tinidazole / therapeutic use
  • Triazoles / therapeutic use
  • Trichomonas Vaginitis / diagnosis
  • Trichomonas Vaginitis / drug therapy
  • Trichomonas Vaginitis / transmission
  • Vaginitis / diagnosis
  • Vaginosis, Bacterial / diagnosis
  • Vaginosis, Bacterial / drug therapy
  • Vulvovaginitis* / diagnosis
  • Vulvovaginitis* / drug therapy

Substances

  • Anti-Infective Agents, Local
  • Antifungal Agents
  • Antitrichomonal Agents
  • Imidazoles
  • Triazoles
  • Tinidazole
  • terconazole
  • Nystatin
  • Itraconazole
  • Ornidazole
  • Miconazole
  • Fluconazole
  • Clotrimazole
  • Ketoconazole
  • tioconazole